Serina Therapeutics

SERNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$58.675 M

$2.31 +2.67%

Close of 21 Sept 2026

Revenue

$130.0K

#3582 by revenue

Earnings

-$19.2M

Loss-making

Shares outstanding

25,400,473

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#346Xilio TherapeuticsXLO$59.4M
#347Nomad Power SolutionsNMAD$59.3M
#348Serina TherapeuticsSER$58.7M
#349Edesa BiotechEDSA$55.5M
#350Dogwood TherapeuticsDWTX$54.4M

What if Serina Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$1,191,870

Per share 515,961× higher

Bitcoin $1.72T

$67,707.55

Per share 29,311× higher

Nvidia $5.48T

$215,738.42

Per share 93,393× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Serina Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.